April 16, 2021
Business News

InVivo Therapeutics Announces Presentation at Upcoming 2021 H.C. Wainwright Global Life Sciences Conference

CAMBRIDGE, Mass.–()–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming 2021 H.C. Wainwright Global Life Sciences Conference. The conference is scheduled to be held March 9-10, 2021 in a virtual format. Dr. Toselli’s presentation will provide an overview of the company and highlight key business updates for the company.

A webcast of the presentation will be available on the Investor Relations – Events section of the InVivo website at

Click here to view the original article.

Related Posts

You might also like ...

AON Splash Image
Census Bureau to Host Educational Webinar to Provide Insights on Upcoming Quality Metrics Release
INTZ CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Intrusion Inc.
Heritage Cannabis Holdings Corp. Reports Annual General and Special Meeting Results